These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32279918)

  • 41. Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease.
    Vrablicova Z; Soltys K; Krajcovicova A; Stuchlikova K; Sturdik I; Koller T; Huorka M; Payer J; Killinger Z; Jackuliak P; Tkacik M; Stuchlik S; Sekac J; Hlavaty T
    Physiol Res; 2019 Nov; 68(Suppl 2):S183-S192. PubMed ID: 31842582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Naftali T; Reshef L; Kovacs A; Porat R; Amir I; Konikoff FM; Gophna U
    Inflamm Bowel Dis; 2016 Feb; 22(2):293-302. PubMed ID: 26752462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.
    Stucchi A; Reed K; O'Brien M; Cerda S; Andrews C; Gower A; Bushell K; Amar S; Leeman S; Becker J
    Inflamm Bowel Dis; 2006 Jul; 12(7):581-7. PubMed ID: 16804395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.
    Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G
    World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crohn's disease recurrence updates: first surgery
    Russo E; Cinci L; Di Gloria L; Baldi S; D'Ambrosio M; Nannini G; Bigagli E; Curini L; Pallecchi M; Andrea Arcese D; Scaringi S; Malentacchi C; Bartolucci G; Ramazzotti M; Luceri C; Amedei A; Giudici F
    Front Immunol; 2022; 13():886468. PubMed ID: 35967326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype.
    Tavares de Sousa H; Gullo I; Castelli C; Dias CC; Rieder F; Carneiro F; Magro F
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00330. PubMed ID: 33848279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease.
    Russo E; Giudici F; Ricci F; Scaringi S; Nannini G; Ficari F; Luceri C; Niccolai E; Baldi S; D'Ambrosio M; Ramazzotti M; Amedei A
    J Crohns Colitis; 2021 Sep; 15(9):1500-1516. PubMed ID: 33611347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
    Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
    Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.
    Chapman CG; Yamaguchi R; Tamura K; Weidner J; Imoto S; Kwon J; Fang H; Yew PY; Marino SR; Miyano S; Nakamura Y; Kiyotani K
    Inflamm Bowel Dis; 2016 Jun; 22(6):1275-85. PubMed ID: 27135481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance.
    Ina K; Itoh J; Fukushima K; Kusugami K; Yamaguchi T; Kyokane K; Imada A; Binion DG; Musso A; West GA; Dobrea GM; McCormick TS; Lapetina EG; Levine AD; Ottaway CA; Fiocchi C
    J Immunol; 1999 Jul; 163(2):1081-90. PubMed ID: 10395708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn's Disease.
    Maddipatla SC; Kolachala VL; Venkateswaran S; Dodd AF; Pelia RS; Geem D; Yin H; Sun Y; Xu C; Mo A; Kosters A; Yang J; Matthews JD; Ghosn E; Kugathasan S; Qiu P
    Inflamm Bowel Dis; 2023 Feb; 29(2):274-285. PubMed ID: 36206201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease.
    Grillo AR; Scarpa M; D'Incà R; Brun P; Scarpa M; Porzionato A; De Caro R; Martines D; Buda A; Angriman I; Palù G; Sturniolo GC; Castagliuolo I
    Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(6):G443-54. PubMed ID: 26185333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility.
    Peck BC; Weiser M; Lee SE; Gipson GR; Iyer VB; Sartor RB; Herfarth HH; Long MD; Hansen JJ; Isaacs KL; Trembath DG; Rahbar R; Sadiq TS; Furey TS; Sethupathy P; Sheikh SZ
    Inflamm Bowel Dis; 2015 Sep; 21(9):2178-87. PubMed ID: 26164662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease.
    Belmiro CL; Souza HS; Elia CC; Castelo-Branco MT; Silva FR; Machado RL; Pavão MS
    Int J Colorectal Dis; 2005 Jul; 20(4):295-304. PubMed ID: 15660268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
    Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
    Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.